文献速递贫血与红细胞疾病MDS 与骨髓增殖性肿瘤

PNH克隆、6p CN-LOH与克隆性TCR基因重排对再生障碍性贫血诊断的预测价值

The predictive value of PNH clones, 6p CN-LOH, and clonal TCR gene rearrangement for aplastic anemia diagnosis.
PubMed 文献 · Blood Adv · 2021-01-01

该研究在454例连续纳入的儿童和成人患者中评估PNH克隆、获得性6p CN-LOH及克隆性TRG重排对再生障碍性贫血(AA)的诊断预测价值。结果显示PNH和累及HLA基因的获得性6p CN-LOH对AA具有约100%的阳性预测值,可辅助约半数AA患者诊断,而克隆性TRG重排对AA不具特异性。作者建议将PNH和6p CN-LOH早期纳入疑似AA的诊断评估,并使用文中的贝叶斯列线图指导临床应用。

要点

  • PNH克隆和累及HLA基因的获得性6p CN-LOH对AA具有约100%的阳性预测值。
  • 上述两项指标可辅助约半数AA患者的诊断,有助于区分AA与遗传性骨髓衰竭综合征。
  • 克隆性TRG重排对AA不具特异性,不宜单独用于AA诊断。

核心结论

  • PNH克隆和获得性6p CN-LOH克隆能有效区分AA与IBMFS,两者应早期纳入疑似AA的诊断评估。
  • 克隆性TRG重排对AA不具特异性,不能作为AA的特异性诊断标志。

研究设计与样本

  • 研究纳入454例连续诊断的儿童和成人患者,涵盖AA、IBMFS及其他血液系统疾病。
  • 检测所有患者的PNH克隆、获得性6p CN-LOH和克隆性TRG重排,并分析其对AA的诊断预测价值。

主要发现

  • PNH和累及HLA基因的获得性6p CN-LOH对AA的阳性预测值约为100%。
  • PNH和6p CN-LOH可辅助约半数AA患者的诊断。
  • 克隆性TRG重排在AA中不具特异性。

关键数值与推荐

  • PNH和获得性6p CN-LOH对AA的阳性预测值约为100%。
  • 上述两项指标可辅助约半数AA患者诊断。

临床怎么用

  • 对疑似AA患者应早期检测PNH克隆和获得性6p CN-LOH。
  • 可结合文中的贝叶斯列线图解读检测结果以指导临床诊断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Acquired aplastic anemia (AA) is a life-threatening bone marrow aplasia caused by the autoimmune destruction of hematopoietic stem and progenitor cells. There are no existing diagnostic tests that definitively establish AA, and diagnosis is currently made via systematic exclusion of various alternative etiologies, including inherited bone marrow failure syndromes (IBMFSs). The exclusion of IBMFSs, which requires syndrome-specific functional and genetic testing, can substantially delay treatment. AA and IBMFSs can have mimicking clinical presentations, and their distinction has significant implications for treatment and family planning, making accurate and prompt diagnosis imperative to optimal patient outcomes. We hypothesized that AA could be distinguished from IBMFSs using 3 laboratory findings specific to the autoimmune pathogenesis of AA: paroxysmal nocturnal hemoglobinuria (PNH) clones, copy-number-neutral loss of heterozygosity in chromosome arm 6p (6p CN-LOH), and clonal T-cell receptor (TCR) γ gene (TRG) rearrangement. To test our hypothesis, we determined the prevalence of PNH, acquired 6p CN-LOH, and clonal TRG rearrangement in 454 consecutive pediatric and adult patients diagnosed with AA, IBMFSs, and other hematologic diseases. Our results indicated that PNH and acquired 6p CN-LOH clones encompassing HLA genes have ∽100% positive predictive value for AA, and they can facilitate diagnosis in approximately one-half of AA patients. In contrast, clonal TRG rearrangement is not specific for AA. Our analysis demonstrates that PNH and 6p CN-LOH clones effectively distinguish AA from IBMFSs, and both measures should be incorporated early in the diagnostic evaluation of suspected AA using the included Bayesian nomogram to inform clinical application.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Shah YB, Priore SF, Li Y, et al. The predictive value of PNH clones, 6p CN-LOH, and clonal TCR gene rearrangement for aplastic anemia diagnosis. Blood Adv. 2021. PMID: 34427585. doi:10.1182/bloodadvances.2021004201

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。